Atlas Trials

Chloroquine in Combination With VELCADE and Cyclophosphamide for Relapsed and Refractory Multiple Myeloma

Clinical trial NCT01438177 · TERMINATED

Trial details

NCT number
NCT01438177
Sponsor
NYU Langone Health
Status
TERMINATED
Phase
Phase 2
Study type
INTERVENTIONAL
Multiple Myeloma
Start date
2011-10-01
Primary completion
2014-02-01
Enrollment
11

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.